Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
L
Lytix Biopharma AS
OSE:LYTIX
Lytix Biopharma AS
OSE:LYTIX
Price:
8.26
NOK
-5.71%
Market Closed
Market Cap:
kr635.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lytix Biopharma AS
OSE:LYTIX
|
NO |
|
Novanta Inc
NASDAQ:NOVT
|
US |
|
Azenta Inc
NASDAQ:AZTA
|
US |
|
A
|
Avista Corp
DUS:AV6
|
US |
|
A
|
Alphabet Inc
BMV:GOOG
|
US |
|
Sartorius Stedim Biotech SA
OTC:SDMHF
|
FR |
|
Media Nusantara Citra Tbk PT
IDX:MNCN
|
ID |
|
Nippon Prologis REIT Inc
TSE:3283
|
JP |
|
Arabian Pipes Company SJSC
SAU:2200
|
SA |
|
S
|
Sun Life Financial Inc
F:LIE
|
CA |
|
First Guaranty Bancshares Inc
NASDAQ:FGBI
|
US |
|
Q
|
Qualys Inc
F:3L7A
|
US |
Wall St Price Targets
LYTIX Price Forecast
Based on 5 analysts
Based on 5 analysts
+85% Upside
from
kr8.26
today
Lytix Biopharma AS (LYTIX)’s 12-month stock price forecast through October 2027 has a consensus target of kr15.3, implying 85% upside. The forecast is based on price targets from 5 Wall Street analysts.
Lytix Biopharma AS Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LYTIX's stock price target?
Price Target
15.3
NOK
15.3
NOK
According to Wall Street analysts, the average 1-year price target for LYTIX is 15.3 NOK with a low forecast of 14.14 NOK and a high forecast of 16.8 NOK.